Vivo Capital »

Regulus Therapeutics shares owned by Vivo Capital

Quarter-by-quarter ownership of Regulus Therapeutics (RGLS) shares owned by Vivo Capital from 13F filings

Historical chart of Vivo Capital investment in Regulus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Regulus Therapeutics held by Vivo Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regulus Therapeutics by Vivo Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $14M 5.0M 2.88

More positions owned by Vivo Capital

Soleno Therapeutics Common (SLNO)
Geron Corp Common (GERN)
Harmony Biosciences Holdings Common (HRMY)
Sinovac Biotech SHS (SVA)
Avadel Pharmaceuticals Adr
Verona Pharma Sponsored Ads (VRNA)
ALX Oncology Holdings Common (ALXO)
Dyne Therapeutics Common (DYN)
Terns Pharmaceuticals Common (TERN)
Astria Therapeutics Common (ATXS)
Viridian Therapeutics Common (VRDN)
Silence Therapeutics Ads (SLN)
Olema Pharmaceuticals Common (OLMA)
Adverum Biotechnologies Common (ADVM)
Alpine Immune Sciences Common

View all positions for Vivo Capital

Top funds holding Regulus Therapeutics

Federated Investors
RA Capital Management
Octagon Capital Advisors
Vanguard Group
BlackRock
Deep Track Capital
Opaleye Management
Geode Capital Management
Millennium Management
State Street Corporation
Woodline Partners
Alyeska Investment Group
DAFNA Capital Management
CVI Holdings
Victory Capital Management

View all funds holding Regulus Therapeutics